FDA Defends Framework As It Dismisses Advocacy Group’s Petition To Put Moratorium On Opioid Approvals

This post was originally published on this site

Public Citizen says the agency displayed “dangerously deficient oversight” when it approved opioids during a growing crisis. The FDA denied the request for a moratorium, pointing to the framework and guidance it has developed in the years since. In addition, the FDA argued that it is not permitted under federal law to impose a moratorium on approving new medicines. In other news: a judge knocks down Purdue Pharma’s efforts to dismiss public nuisance claims and the AMA is urging states to be proactive on opioid abuse treatment.